CYCLACEL PHARMACEUTICALS INC (CYCC)

US23254L8019 - Common Stock

2.79  -0.18 (-6.06%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

MRQ
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
ASSETS
Current Assets
Cash
N/AN/AN/AN/AN/A
Cash Equivalents
10.16M18.35M36.56M33.41M11.89M
Marketable Securities
N/AN/AN/AN/AN/A
Receivables
1.95M4.66M3.73M1.31M1.33M
Other Current Assets
3.18M1.41M660.00K750.00K800.00K
Total Current Assets
15.29M24.41M40.94M35.47M14.02M
 
Non-Current Assets
PPE Net
150.00K170.00K90.00K1.33M1.29M
Other Non-Current Assets
1.00M2.92M1.55MN/AN/A
Total Non-Current Assets
1.15M3.09M1.65M1.33M1.29M
 
TOTAL ASSETS
16.44M27.50M42.59M36.80M15.31M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
4.34M3.94M2.54M1.11M850.00K
Accounts Payable
2.17M2.56M2.12M510.00K890.00K
Other Current Liabilities
230.00K890.00K630.00K870.00K680.00K
Total Current Liabilities
6.75M7.39M5.29M2.49M2.42M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
70.00K110.00K30.00K1.06M1.19M
Total Non-Current Liabilities
60.00K110.00K30.00K1.05M1.19M
 
TOTAL LIABILITIES
6.81M7.50M5.32M3.54M3.61M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-417.41M-406.16M-384.96M-366.07M-357.63M
Additional Paid In Capital
423.63M422.97M422.96M400.07M370.13M
Common Shares
4.50M4.50M10.00K10.00K20.00K
Other Shareholders' Equity
-1.10M-1.32M-750.00K-750.00K-820.00K
Shares Outstanding
12.64M12.54M9.99M6.25M860.00K
Tangible Book Value per Share
0.761.593.735.3213.60
Total Shareholders' Equity
9.63M20.00M37.26M33.26M11.70M
 
TOTAL LIABILITIES AND EQUITY
16.44M27.50M42.59M36.80M15.31M
 
Statistics
Current Ratio
2.273.307.7414.245.79
Return On Assets (ROA)
-145.80%-77.82%-44.82%-33.75%-52.45%
Return On Equity (ROE)
-248.91%-107.00%-51.23%-37.34%-68.63%

All data in USD

Charts